FLASH Pilot Phase 1 Safety Study
NCT: NCT07608549 · NOT_YET_RECRUITING
Brief Summary
The primary purpose of this research trial is to study the safety of electron FLASH treatment for cutaneous lymphoma lesions. In addition, investigators will confirm the accuracy of dose and dose rate delivery of electron FLASH therapy using on-patient dosimetry measurements in combination with FAST camera imaging. Researchers will also determine the response rates of cutaneous lymphomas treated with a low radiation dose in a single fraction using electron UHDR treatments, followed by an assessment of radiation related skin toxicity.
Frequently Asked Questions
What is FLASH Pilot Phase 1 Safety Study?
FLASH Pilot Phase 1 Safety Study is a clinical trial registered under NCT07608549. Current status: NOT_YET_RECRUITING.
What is the status of NCT07608549?
The current status of NCT07608549 (FLASH Pilot Phase 1 Safety Study) is: NOT_YET_RECRUITING.
When did FLASH Pilot Phase 1 Safety Study start?
FLASH Pilot Phase 1 Safety Study started on 2029-10-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.